当前位置:首页 - 行情中心 - 精华制药(002349) - 财务分析 - 现金流量表

精华制药

(002349)

  

流通市值:61.14亿  总市值:62.31亿
流通股本:8.14亿   总股本:8.30亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金712,736,551.48356,259,418.751,391,635,115.641,005,081,643.31
  收到的税费返还36,020.36655.75211,319.03170,824.33
  收到其他与经营活动有关的现金22,814,198.869,715,305.9160,650,347.4749,554,623.32
  经营活动现金流入小计735,586,770.7365,975,380.411,452,496,782.141,054,807,090.96
  购买商品、接受劳务支付的现金244,518,755.38117,998,241.56472,276,173.88361,844,416.18
  支付给职工以及为职工支付的现金182,775,435.3198,809,298.56315,654,346.93244,751,640.35
  支付的各项税费83,426,414.4939,741,180.37156,757,094.33123,894,368.08
  支付其他与经营活动有关的现金97,179,832.4847,825,407.2196,790,717.76141,466,498.67
  经营活动现金流出小计607,900,437.66304,374,127.691,141,478,332.9871,956,923.28
  经营活动产生的现金流量净额127,686,333.0461,601,252.72311,018,449.24182,850,167.68
二、投资活动产生的现金流量:
  收回投资收到的现金681,000,000275,000,000885,473,316.1656,137,829.1
  取得投资收益收到的现金2,188,021.2484,220.229,476,081.768,672,072.17
  处置固定资产、无形资产和其他长期资产收回的现金净额31,00031,000115,200-
  收到的其他与投资活动有关的现金--46,217,212.4446,047,012.44
  投资活动现金流入小计683,219,021.2275,515,220.22941,281,810.3710,856,913.71
  购建固定资产、无形资产和其他长期资产支付的现金9,017,610.455,414,710.6430,922,944.6326,665,852.26
  投资支付的现金865,700,000357,000,000665,000,000380,000,000
  支付其他与投资活动有关的现金121,000,000-351,167,825.161,117,714.05
  投资活动现金流出小计995,717,610.45362,414,710.641,047,090,769.79407,783,566.31
  投资活动产生的现金流量净额-312,498,589.25-86,899,490.42-105,808,959.49303,073,347.4
三、筹资活动产生的现金流量:
  吸收投资收到的现金56,708,040---
  取得借款收到的现金--10,000,00010,000,000
  收到其他与筹资活动有关的现金8,296-678,724.78-
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计56,716,336-10,678,724.7810,000,000
  偿还债务支付的现金10,000,000-20,900,00016,000,000
  分配股利、利润或偿付利息支付的现金84,948,612.956,75096,456,382.4896,394,847.42
  其中:子公司支付给少数股东的股利、利润--20,911,040-
  支付其他与筹资活动有关的现金573,685.69413,209.981,343,921.52293,700
  筹资活动现金流出小计95,522,298.59469,959.98118,700,304112,688,547.42
  筹资活动产生的现金流量净额-38,805,962.59-469,959.98-108,021,579.22-102,688,547.42
四、汇率变动对现金及现金等价物的影响-432,880.12-48,758.592,133,396.08-509,977.64
五、现金及现金等价物净增加额-224,051,098.92-25,816,956.2799,321,306.61382,724,990.02
  加:期初现金及现金等价物余额1,013,520,736.471,013,520,736.47914,199,429.86914,199,429.86
  期末现金及现金等价物余额789,469,637.55987,703,780.21,013,520,736.471,296,924,419.88
补充资料:
  净利润151,686,598.43-247,466,264.86-
  资产减值准备4,927,023.94-18,661,687.38-
  固定资产和投资性房地产折旧37,645,326.04-72,994,590.18-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧37,645,326.04-72,994,590.18-
  无形资产摊销1,072,945.74-2,144,147.94-
  处置固定资产、无形资产和其他长期资产的损失-28,384.68-202,291.53-
  固定资产报废损失--1,035,789.55-
  公允价值变动损失-1,451,220.5--3,816,186.27-
  财务费用-2,881,097.39--6,474,816.65-
  投资损失-1,434,037.28--4,372,311.26-
  递延所得税334,193.16--570,035.7-
  其中:递延所得税资产减少-23,703.23-241,954.72-
    递延所得税负债增加357,896.39--811,990.42-
  存货的减少-12,659,133.76-6,434,179.92-
  经营性应收项目的减少-55,089,953.71--11,167,434.72-
  经营性应付项目的增加5,016,187.49--17,323,500.07-
  其他--4,437,662.96-
  融资租入固定资产--729,396.39-
  现金的期末余额789,469,637.55-1,013,520,736.47-
  减:现金的期初余额1,013,520,736.47-914,199,429.86-
  现金及现金等价物的净增加额-224,051,098.92-99,321,306.61-
公告日期2025-08-302025-04-302025-04-152024-10-30
审计意见(境内)标准无保留意见
TOP↑